Alterity Therapeutics Growth Metrics (2016-2025) | ATHE

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) -22.57%-17.86%-24.59%-26.07%-99.93%60,068.82%-1.62%-99.90%-53.44%176.28%298.28%19.72%14.55%-32.99%-99.08%-34.13%4,537.63%-52.26%132.67%441.83%
Assets Growth (3y) (Quarter) -92.42%614.90%-91.79%-24.30%-93.01%17.47%22.19%-85.22%28.55%30.38%-65.22%-19.16%-21.17%-40.49%-0.17%19.44%
Assets Growth (5y) (Quarter) -81.80%-0.31%-74.75%7.49%-72.54%5.39%-54.61%-73.04%-1.90%-6.97%35.33%6.45%
Capital Expenditures Growth (1y) (Quarter) 84.56%8.53%-118.19%
Capital Expenditures Growth (3y) (Quarter) 32.45%
Cash & Equivalents Growth (1y) (Quarter) -21.33%-15.38%-23.00%-27.98%-29.84%-60.72%-12.55%38.35%-40.24%207.84%259.18%5.24%15.15%-38.24%-99.37%-51.82%-19.87%-63.01%16,702.03%988.88%
Cash & Equivalents Growth (3y) (Quarter) -24.82%-37.91%-22.12%-26.85%-28.43%18.71%23.36%64.88%35.21%26.01%-70.31%-32.09%-81.99%-52.08%-5.21%24.73%
Cash & Equivalents Growth (5y) (Quarter) -25.99%0.39%0.28%4.86%8.68%1.69%-57.62%5.93%-58.35%-18.64%28.64%4.75%
Cash from Investing Activities Growth (1y) (Quarter) 84.56%8.53%-118.19%
Cash from Investing Activities Growth (3y) (Quarter) 32.45%
Cash from Operations Growth (1y) (Quarter) 20.46%-93.60%98.93%-474.49%-20,575.33%65.90%36.76%
Cash from Operations Growth (3y) (Quarter) -20.84%-55.94%-11.95%
EBIT Growth (1y) (Quarter) -1.55%-37.71%-0.58%
EBIT Growth (3y) (Quarter) -12.04%
EBT Growth (1y) (Quarter) -1.55%-37.71%-0.58%
EBT Growth (3y) (Quarter) -12.04%
Enterprise Value Growth (1y) (Quarter) 21.33%15.38%22.47%27.41%30.32%61.03%12.55%-38.35%40.24%-207.84%-259.18%-5.24%-15.19%38.24%99.26%51.82%-4,433.63%63.01%-154.46%-988.88%
Enterprise Value Growth (3y) (Quarter) 24.82%37.91%22.12%26.85%28.59%-18.40%-23.36%-64.88%-35.22%-26.01%68.73%32.09%27.19%52.08%5.18%-24.73%
Enterprise Value Growth (5y) (Quarter) 25.99%-0.39%-0.28%-4.86%-8.54%-1.53%56.28%-5.93%3.69%18.64%-28.67%-4.75%
EPS (Basic) Growth (1y) (Quarter) -111.23%35.24%-151.86%
EPS (Basic) Growth (3y) (Quarter) -51.04%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -1.87%-34.29%-151.86%
EPS (Weighted Average and Diluted) Growth (3y) (Quarter) -51.04%
Free Cash Flow Growth (1y) (Quarter) 20.46%-100.19%98.93%-475.87%-20,575.33%65.99%36.76%
Free Cash Flow Growth (3y) (Quarter) -20.84%-57.69%-11.95%
Net Cash Flow Growth (1y) (Quarter) 20.46%-56.04%98.93%-444.27%-20,575.33%68.41%36.76%
Net Cash Flow Growth (3y) (Quarter) -20.84%-38.95%-11.95%
Net Income Growth (1y) (Quarter) -1.55%-37.71%-0.58%
Net Income Growth (3y) (Quarter) -12.04%
Net Income towards Common Stockholders Growth (1y) (Quarter) -1.55%-37.71%-0.58%
Net Income towards Common Stockholders Growth (3y) (Quarter) -12.04%
Profit After Tax Growth (1y) (Quarter) 1.84%-1.55%98.90%237.71%-13,711.19%-200.58%23.71%-0.10%-36.64%
Profit After Tax Growth (3y) (Quarter) -14.40%-12.04%-5.18%-2.57%-12.29%
Profit After Tax Growth (5y) (Quarter) -10.48%-172.11%-8.10%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 133.57%-36.85%-24.18%-6.87%204.63%-43.79%-48.68%-88.37%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) 3.80%-23.60%29.09%16.83%-4.22%-67.75%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) 25.98%-5.25%-9.10%-37.52%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.00-1.00-1.000.001.00
Return on Assets Growth (3y) (Quarter) -1.00-1.000.000.00
Shareholder's Equity Growth (1y) (Quarter) -24.02%-31.59%-4.75%-59.58%400.64%8.27%-39.98%-15.31%-1,220.35%
Shareholder's Equity Growth (3y) (Quarter) -20.89%-35.90%24.45%29.88%48.17%-18.05%-97.42%
Shareholder's Equity Growth (5y) (Quarter) 0.04%7.38%4.60%2.17%-101.07%